IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update

IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 13, 2025 R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced ovarian cancer Company to hold conference call today at 11:00 a.m. ET LAWRENCEVILLE, […]

SueWallSt Podcast Explains Class Action Against aTyr Pharma, Inc. (ATYR)

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding aTyr Pharma, Inc. (NASDAQ:ATYR) class action securities lawsuit A Class Action lawsuit was filed on behalf of aTyr Pharma, Inc. investors who lost money as a result of alleged securities fraud between November 7, 2024 and

Domain Therapeutics Appoints Boston-Based Pharma Leader Jean-Marie Cuillerot, M.D., as Chief Medical Officer

• Internationally recognized clinical strategist with proven track record in translating innovation into clinical impact joins Domain to advance its GPCR-targeting pipeline • Appointment comes at a pivotal moment, following the initiation of Phase I/II development of DT-7012, a Treg-depleting anti-CCR8 antibody candidate Domain Therapeutics (“Domain” or “the Company”), theGPCR experts harnessing deep receptor biology

Cylinder Health strengthens gut-brain leadership with new Head of Gut-Brain Health and Clinical Advisory Board appointment

CHICAGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Cylinder Health, the leading virtual digestive health provider integrating gastroenterology, nutrition, and behavioral care (formerly known as Vivante Health), today announced the appointment of two nationally recognized experts in behavioral health to its Clinical Advisory Board. Dr. Grace Niu, Ph.D., joins as Head of Gut-Brain Health, and Dr.

Cylinder Health strengthens gut-brain leadership with new Head of Gut-Brain Health and Clinical Advisory Board appointment

Cylinder Health strengthens gut-brain leadership with new Head of Gut-Brain Health and Clinical Advisory Board appointment Dr. Grace Niu named Head of Gut-Brain Health; Dr. Ujjwal Ramtekkar joins Clinical Advisory Board to expand access to integrated digestive and behavioral care nationwide GlobeNewswire November 13, 2025 CHICAGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Cylinder Health, the

SueWallSt Podcast Series Launches With Focus on WPP plc (WPP) Fraud Allegations

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding WPP plc (NYSE:WPP) class action securities lawsuit A Class Action lawsuit was filed on behalf of WPP plc investors who lost money as a result of alleged securities fraud between February 27, 2025 and July 8,

IFS Partners with Anthropic to Develop Powerful Industrial AI Solutions, Accelerating the Next Industrial Revolution

New breed of IFS Nexus Black Industrial AI solutions, powered by Claude, helps frontline workers keep factory lines moving, restore power 40% faster after disasters, and maintain critical infrastructure assets Today at IFS Industrial X Unleashed, IFS Nexus Black and Anthropic announced a partnership to accelerate and scale the impact of AI in the world's

Marriott International Named One of the Top 2025 World’s Best Workplaces by Fortune and Great Place To Work

Today, Marriott International, Inc. announced it has been named one of the top five World's Best Workplaces by Great Place To Work® andFortune magazine. https://mma.prnewswire.com/media/2821597/worlds_best_announcement.jpg “We are honored to once again be named one of the world's best workplaces. This recognition reflects Marriott's longstanding commitment to excellence and our people-first culture that continues to be

aTyr Pharma, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – ATYR

LOS ANGELES, Nov. 13, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders

aTyr Pharma, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – ATYR

aTyr Pharma, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – ATYR GlobeNewswire November 13, 2025 LOS ANGELES, Nov. 13, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations

Scroll to Top